Previous 10 | Next 10 |
2023-05-08 08:30:11 ET Catalent ( NYSE: CTLT ) is delaying the filing of its FQ3 results and noted that it expects to significantly reduce its fiscal 2023 net revenue and adjusted EBITDA outlook by more than $400M each. The company was scheduled to report its FQ3 results on May ...
2023-05-08 08:17:24 ET MDJM ( MDJH ) -27% . Catalent ( CTLT ) -20% on rejecting TRC Capital's tender offer for shares BioXcel Therapeutics ( BTAI ) -15% after Q1 earning release . Baosheng Media Group Holdings ( BAOS ) -13% . Minim (...
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will be delaying the release of its third fiscal quarter results and investor conference call, previously scheduled for Tuesday, May 9, 2023. The Com...
2023-05-08 05:55:21 ET Catalent ( NYSE: CTLT ) on Friday recommended its stockholders to reject a mini-tender offer from TRC Capital Investment to buy up to 2M common shares of the company at $42.95 apiece in cash. The company said TRC's offer price is ~4.43% lower than ...
Catalent, Inc. (“Catalent”) (NYSE: CTLT) has been notified of an unsolicited “mini-tender offer” by TRC Capital Investment Corporation (“TRC”) to purchase up to 2,000,000 shares of Catalent’s common stock at a price of $42.95 per share in cash. TRC...
2023-04-28 12:26:51 ET Catalent ( NYSE: CTLT ) rose 5% amid reports that the contract research firm canceled out of a William Blair conference in June. Catalent ( CTLT ) canceled it appearance at the William Blair growth conference in Chicago in early June due to the r...
2023-04-26 10:24:33 ET Catalent ( NYSE: CTLT ) ticked up 0.3% amid speculation that Danaher ( NYSE: DHR ) may still be interested in a takeover even after a report last Monday that the life-science company ended its pursuit. Danaherfell 1%. Comments that Danaher ...
2023-04-25 17:11:31 ET The hits just keep coming for Catalent (NYSE: CTLT) stock, and not in a good way. In line with a recent trend, the contract drug manufacturer's shares suffered a notable fall on Tuesday, declining by almost 6% in price. That wasn't altogether surprising, given...
2023-04-20 14:20:09 ET Summary Catalent is a contract manufacturer catering to the pharmaceutical industry. The company's share price rose >$120 during the pandemic owing to the additional revenues the company earned helping manufacture COVID vaccines. The company's share p...
2023-04-18 19:18:43 ET The latest barrage of earnings reports failed to move the overall stock market, as the major U.S. equity averages finished the session nearly unchanged. The S&P 500 edged up less than 0.1%. Despite the general malaise, travel stocks managed to push higher. Thi...
News, Short Squeeze, Breakout and More Instantly...
Expansion adds more temperature-controlled storage and dedicated space for FastChain ® demand-led supply service Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansio...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...